Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Abingdon Health acquires IVDeology in £0.7m deal
(Sharecast News) - Lateral flow contract research, development and manufacturing provider Abingdon Health announced the acquisition of IVDeology and its subsidiaries on Tuesday, for up to £0.7m. The AIM-traded firm said IVDeology, based in the UK, provides regulatory consultancy support to a global clientele in the in vitro diagnostics sector.
It said it offers a range of regulatory services tailored to meet the requirements of different markets, including support for the in vitro medical devices regulation (IVDR) for the EU market, UK Conformity Assessed (UKCA) marking for the UK market, and FDA support for the US market.
Services include technical file construction, regulatory filing assistance, implementation of Quality Management Systems, and Quality Assurance.
Additionally, IVDeology acts as the UK responsible person for non-UK manufacturers seeking to register their products in the UK market.
Regulatory experts Stuart Angell and Nancy Consterdine co-founded IVDeology, and would continue to lead the organisation within the broader Abingdon Health group.
The board said the strategic acquisition would fortify Abingdon's position as a leader in regulatory services within the in vitro diagnostics sector.
With ongoing regulatory changes such as the implementation of IVDR in Europe, the introduction of UKCA marking in the UK, and recent alterations in the classification of lateral flow products in the United States, there was growing demand for expert regulatory guidance.
Abingdon said it aimed to leverage IVDeology's expertise to support its existing and new clients in navigating the evolving regulatory landscape, enhancing its service offerings.
Consideration for the acquisition would amount to up to £0.7m, to be satisfied through the issue of five million shares in Abingdon Health to the owners of IVDeology.
The initial consideration of £0.5m would be subject to a 12-month lock-in agreement, with additional shares potentially issued based on achieving certain revenue targets in the two financial years following acquisition.
IVDeology recorded a combined turnover of £0.39m in the financial year ended 31 January, with net assets valued at £0.04m on the same date.
"The acquisition of IVDeology is in line with Abingdon's strategy of providing our customers with all the pieces of the jigsaw required to bring products from idea to commercial success," said chief executive officer Chris Yates.
"The IVDeology team will strengthen Abingdon's existing knowledge leadership and regulatory expertise.
"We look forward to working with the IVDeology team and supporting existing and new customers in navigating a regulatory environment going through a period of significant change."
At 1251 BST, shares in Abingdon Health were up 7.13% at 10.44p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.